Group Support for Patients With Schizophrenia

This article appeared June 28 in the online edition of ADVANCE.

1. Substance Abuse and Mental Health Services Administration, Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-44, DHHS Publication No. SMA 12-4713. Rockville, MD: SAMHSA, 2012.
2. The World Health Organization. The global burden of disease: 2004 update, Table A2: Burden of disease in DALYs by cause, sex and income group in WHO regions, estimates for 2004. Geneva, Switzerland: WHO, 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_AnnexA.pdf.
3. New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in America Executive Summary. July 2003, Rockville, MD.
4. http://www.nami.org/
5. Shean, G.D. (2007). Recent developments in psychosocial treatments for schizophrenic patients. Expert Review of Neurotherapeutics, 7(7):817-28.
6. Muench, J. MD, MPH, and Hamer, A., PharmD, BCPP. (2010). Adverse Effects of Antipsychotic Medications. American Family Physician, 81(5)617-622.
7. Dixon, L., Dickerson, F., Bellack, A. et al. (2010). The 2009 Schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin. 36(1):48-70, 2010. Jan.
8. Rosenbaum, B., et al. (2012). Supportive Psychodynamic Psychotherapy versus Treatment as Usual for First-Episode Psychosis: Two-Year Outcome. Psychiatry: Interpersonal & Biological Processes, Guilford Publications Inc. 75(4)331-341. Winter 2012.

About The Author